Maxine Gowen's Net Worth
$124 Thousand
Who is Maxine Gowen?
Maxine Gowen does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Merus N.V., Aclaris Therapeutics, Inc., TREVENA INC, Aceragen, Inc., Passage BIO, Inc., Akebia Therapeutics, Inc., SANTARUS INC, and HUMAN GENOME SCIENCES INC.
SEC CIK
Maxine Gowen's CIK is 0001280044
Past Insider Trading and Trends
2016 was Maxine Gowen's most active year for acquiring shares with 15 total transactions. Maxine Gowen's most active month to acquire stocks was the month of May. 2017 was Maxine Gowen's most active year for disposing of shares, totalling 8 transactions. Maxine Gowen's most active month to dispose stocks was the month of June. 2004 saw Maxine Gowen paying a total of $180,000.00 for 1,207,656 shares, this is the most they've acquired in one year. In 2012 Maxine Gowen cashed out on 101,663.14 shares for a total of $1,448,699.74, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Merus N.V. (MRUS) Snapshot price: $37.67
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aclaris Therapeutics, Inc. (ACRS) Snapshot price: $1.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| +37.88% | 4.66K |
—
|
—
| 16.96K |
Jun 1
| |||
Form 4
| +57.83% | 4.51K |
—
|
—
| 12.3K |
Jun 1 - Jun 2
| |||
Form 4
| +75.62% | 3.36K |
—
|
—
| 7.79K |
Jun 2 - Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
∞
| 4.44K |
—
|
—
| 4.44K |
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TREVENA INC (TRVN) Snapshot price: $0.61
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
| +1,250.00% | 50K |
$1.02 | $51,000.00 | 54K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 28
| |||
Form 4
|
—
|
0
|
—
|
—
| 771.62K |
Jan 6 - May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
| +669.11% | 110.4K |
$0.68 | $75,294.85 | 126.9K |
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
| +312.50% | 12.5K |
$4.10 | $51,250.00 | 16.5K |
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
| 297.11K |
Oct 20
| |||
Form 4
|
—
|
0
|
—
|
—
| 297.11K |
Sep 29 - Oct 17
| |||
Form 4
| +8.03% | 22.08K |
$7.15 | $157,274.72 | 297.11K |
May 26 - May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
| -15.64% | -51.00K |
—
|
—
| 275.02K |
Feb 20 - Mar 17
| |||
Form 4
| +2.52% | 8K |
$4.00 | $32,000.00 | 326.02K |
Dec 10
| |||
Form 4
| +64.31% | 124.48K |
$0.68 | $84,893.31 | 318.02K |
Apr 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aceragen, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -51.00 |
$0.51 | -$26.01 |
0
|
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
| +66.39% | 7K |
$1.50 | $10,500.00 | 17.54K |
Jan 4
| |||
Form 4
| +63.69% | 4.1K |
$2.56 | $10,501.12 | 10.54K |
Oct 3
| |||
Form 4
|
∞
| 6.44K |
$1.63 | $10,498.83 | 6.44K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Passage BIO, Inc. (PASG) Snapshot price: $1.02
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||